ArticleNeuro-oncology2013

Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.

Aurélien Corroyer-Dulmont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.